Home > Financial Ratios > CORONA REMEDIES

CORONA REMEDIES
EBIT Growth

    Back to All Ratios
CORONA REMEDIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for CORONA REMEDIES
Please provide your vote to see the results

CORONA REMEDIES Last 5 Year EBIT Growth History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023
   EBIT Growth(%) 18.2957.3415.43-

What is the latest EBIT Growth ratio of CORONA REMEDIES ?

The latest EBIT Growth ratio of CORONA REMEDIES is 18.29 based on Mar2026 Consolidated results.
Year EBIT Growth
Mar202618.29
Mar202557.34
Mar202415.43
Mar2023-

How is EBIT Growth of CORONA REMEDIES Trending?

Years EBIT Growth % Change
Mar2026 18.29
-68.10
Mar2025 57.34
271.61
Mar2024 15.43
0
Mar2023 0 -

Other Financial Ratios of CORONA REMEDIES


Compare EBIT Growth ratio of peers of CORONA REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CORONA REMEDIES ₹12,310.7 Cr -0.6% -7% NA Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,684.0 Cr -1.4% -6.5% 5.5% Stock Analytics
DIVIS LABORATORIES ₹241,311.0 Cr -2% -2.7% 40.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹173,079.0 Cr -1.8% -7% 29.6% Stock Analytics
CIPLA ₹107,528.0 Cr 0.1% -3% -15.3% Stock Analytics
DR REDDYS LABORATORIES ₹103,667.0 Cr 0.2% 6% -2.4% Stock Analytics


CORONA REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
CORONA REMEDIES

-0.6%

-7%

NA
SENSEX

2.7%

-0.7%

-10.5%


You may also like the below Video Courses